Publications by authors named "Oleg Gligich"

Importance: Glioblastoma is the most lethal primary brain cancer. Clinical outcomes for glioblastoma remain poor, and new treatments are needed.

Objective: To investigate whether adding autologous tumor lysate-loaded dendritic cell vaccine (DCVax-L) to standard of care (SOC) extends survival among patients with glioblastoma.

View Article and Find Full Text PDF

The patient denied recent trauma or any heavy lifting, but she'd lost 10 pounds over the previous month. What was causing her shoulder pain?

View Article and Find Full Text PDF

The role of viral co-infections and paraproteins in the development of hematological malignancies (HMs) in HIV remains unclear. Using our large database of HIV+ patients, we investigated whether co-infection and paraproteinemia increase the risk of HM. Data on demographics, hepatitis B (HBV) and hepatitis C virus (HCV) co-infections, paraproteinemia, HIV characteristics, and biopsy proven malignant hematological disorders for HIV+ patients were collected over a 10-year period in a large urban hospital setting.

View Article and Find Full Text PDF

The significance of HIV associated paraproteins and their risk of progression to hematological malignancies remains unclear. We compared the development of hematological malignancies among HIV+ (n = 266) and HIV- (n = 537) patients with monoclonal gammopathies. HIV+ and HIV- patients with a positive serum protein electrophoresis test (SPEP) were studied.

View Article and Find Full Text PDF
Article Synopsis
  • - Myelodysplastic syndromes (MDS) are blood disorders leading to low blood counts and can evolve into leukemia; however, the primary issues for patients usually stem from chronic low counts rather than the transformation.
  • - Traditional treatments for MDS have mixed results and significant side effects, particularly for older patients, which creates a need for targeted therapies that can improve blood counts and address bone marrow failure.
  • - Various targeted strategies are being researched, including inhibitors for specific signaling pathways (like p38 MAPK and TGF-β), which have shown promising results in clinical trials, highlighting the potential for more effective treatments for MDS.
View Article and Find Full Text PDF

Differentiation of hematopoietic stem cells to red cells requires coordinated expression of numerous erythroid genes and is characterized by nuclear condensation and extrusion during terminal development. To understand the regulatory mechanisms governing these widespread phenotypic changes, we conducted a high resolution methylomic and transcriptomic analysis of six major stages of human erythroid differentiation. We observed widespread epigenetic differences between early and late stages of erythropoiesis with progressive loss of methylation being the dominant change during differentiation.

View Article and Find Full Text PDF